Nachman Norwood & Parrott’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $3.41M | Buy |
50,961
+42
| +0.1% | +$2.81K | 0.35% | 61 |
|
|
2021
Q1 | $3.22M | Buy |
50,919
+62
| +0.1% | +$3.92K | 0.35% | 58 |
|
|
2020
Q4 | $3.15M | Buy |
50,857
+1,059
| +2% | +$65.7K | 0.37% | 54 |
|
|
2020
Q3 | $3M | Buy |
49,798
+347
| +0.7% | +$20.9K | 0.4% | 49 |
|
|
2020
Q2 | $2.91M | Buy |
49,451
+186
| +0.4% | +$10.9K | 0.48% | 40 |
|
|
2020
Q1 | $2.75M | Sell |
49,265
-20
| -0% | -$1.12K | 0.55% | 37 |
|
|
2019
Q4 | $3.16M | Sell |
49,285
-1,284
| -3% | -$82.4K | 0.52% | 37 |
|
|
2019
Q3 | $2.56M | Buy |
50,569
+181
| +0.4% | +$9.18K | 0.46% | 47 |
|
|
2019
Q2 | $2.29M | Buy |
50,388
+1,687
| +3% | +$76.5K | 0.41% | 55 |
|
|
2019
Q1 | $2.32M | Sell |
48,701
-272
| -0.6% | -$13K | 0.43% | 55 |
|
|
2018
Q4 | $2.55M | Buy |
+48,973
| New | +$2.55M | 0.53% | 38 |
|